日本薬理学会年会要旨集
Online ISSN : 2435-4953
第96回日本薬理学会年会
セッションID: 96_4-B-O12-6
会議情報

一般演題(口頭)
ヒアルロン酸ナノゲルを用いたシクロスポリンの徐放化に関する検討
橋本 桂樹宇佐美 歩樹森 理人伊藤 宏輔薄田 菜々子曽田 翠勝又 徹薮内 昂平中井 貴士*北市 清幸
著者情報
会議録・要旨集 オープンアクセス

詳細
抄録

Hyaluronic acid (HA) nanogel is derived by the partial modification of hyaluronicacid with cholesterol, causing the formation of self-assembled nanometer-scalehydrogel in water. Thus, HA nanogels might contribute to alter drug delivery ofpoorly water-soluble drugs. In this study, we tried to investigate the effect ofHA nanogels by using cyclosporine (CyA) in rats. HA nanogels (Asahi Kasei Co, 5mL/kg) containing CyA (2.5-15 mg/kg) were subcutaneously administered in male SDrats (Charles River) and whole blood samples were collected at the designatedtime-points up to 28 days. The concentrations of CyA were measured usingLC-MS/MS 6045 (Shimadzu). In rats administered CyA without HA nanogel (controlgroup), the concentration of CyA was below the detection limit (3 ng/mL) on 7days after administration. Some formulas of HA nanogel showed thesustained-release properties of CyA. Interestingly, one formula could bedetectable up to at least 10 days after administration. HA nanogels would beuseful as a tool to alter drug delivery of poorly water-soluble drugs such asCyA.

著者関連情報
© 2022 本論文著者
前の記事 次の記事
feedback
Top